Check out the online TTS 2024 Program

Time	Room	Session
07:00 - 08:00 \| Morning Sessions
07:00-08:00	MOA 6	MOA 6 07:00 Morning Session: SickKids: Empowering adolescents: Team-based multidisciplinary care Full Details A light breakfast will be served Session Sponsored by: Amelia Marrato, Canada Panelist: Nurse practitioner perspective Amelia Marrato, Canada Panelist: Nurse practitioner perspective Louise Bannister, Canada Panelist: Dietitian perspective Louise Bannister, Canada Panelist: Dietitian perspective Anna Gold, Canada Panelist: Psychologist perspective Anna Gold, Canada Panelist: Psychologist perspective Akila Dada, Canada Panelist: Child life specialist perspective Akila Dada, Canada Panelist: Child life specialist perspective Alison Schwartz, Canada Panelist: Occupational therapist perspective Alison Schwartz, Canada Panelist: Occupational therapist perspective Robin Deliva, Canada Panelist: Physical therapist perspective Robin Deliva, Canada Panelist: Physical therapist perspective
07:00-07:50	MOA 5	MOA 5 07:00 Oral Abstract: Understanding rejection in pediatric kidney transplant Full Details Alanoud Alshami, Saudi Arabia Utility of De Novo Donor-Specific Antibody-Driven Protocol Kidney Biopsy in Pediatric Kidney Transplantaion Alanoud Alshami, Saudi Arabia Utility of De Novo Donor-Specific Antibody-Driven Protocol Kidney Biopsy in Pediatric Kidney Transplantaion Jessica Schmitz, Germany Immunohistochemical and molecular characterization of immune cells in pediatric renal allografts: mononuclear phagocytes correlate with rejection, retransplantation, graft function and fibrosis Jessica Schmitz, Germany Immunohistochemical and molecular characterization of immune cells in pediatric renal allografts: mononuclear phagocytes correlate with rejection, retransplantation, graft function and fibrosis Evgenia Preka, France Urinary and blood mRNA biomarkers for detecting kidney allograft rejection in adults (The KTD-Innov study: NCT03582436) Evgenia Preka, France Urinary and blood mRNA biomarkers for detecting kidney allograft rejection in adults (The KTD-Innov study: NCT03582436) Anika Shah, United States Impact of Specific HLA-DR Mismatches on De Novo Donor-Specific Antibody Formation in Pediatric Kidney Transplantation Anika Shah, United States Impact of Specific HLA-DR Mismatches on De Novo Donor-Specific Antibody Formation in Pediatric Kidney Transplantation Clarkson Crane, United States Use of tissue-based gene expression alongside histology improves clinical decision-making in pediatric kidney transplant recipients Clarkson Crane, United States Use of tissue-based gene expression alongside histology improves clinical decision-making in pediatric kidney transplant recipients
07:00-07:50	MOA 3	MOA 3 07:00 Oral Abstract: Advances in transplant surgery Full Details Joao Seda Neto, Brazil Anterior hepatic resection for infant LDLT: Medium-term outcomes Joao Seda Neto, Brazil Anterior hepatic resection for infant LDLT: Medium-term outcomes Amanda R Jensen, United States Split liver transplantation using machine perfusion in pediatric recipients Amanda R Jensen, United States Split liver transplantation using machine perfusion in pediatric recipients Renana Yemini, United States Intra-operative flow rates in technical variant pediatric liver transplantation: Measurement distribution and a potential predictor of post-operative vascular complications – A Starzl Network Initiative Renana Yemini, United States Intra-operative flow rates in technical variant pediatric liver transplantation: Measurement distribution and a potential predictor of post-operative vascular complications – A Starzl Network Initiative Isabela GG Santos, Australia Australian experience with APOLT in children with FLF Isabela GG Santos, Australia Australian experience with APOLT in children with FLF Reza Saidi, United States Single vs. en bloc kidney transplantation from donors ≤5 years of age in the United States: An analysis of the scientific registry of transplant recipients (SRTR) from 1987 to 2023 Reza Saidi, United States Single vs. en bloc kidney transplantation from donors ≤5 years of age in the United States: An analysis of the scientific registry of transplant recipients (SRTR) from 1987 to 2023
08:00 - 09:30 \| Plenary Session
08:00-09:30	MOA 9 (Plenary Room)	MOA 9 (Plenary Room) 08:00 Plenary Session: Artificial Intelligence (AI) in Health Care: Integration of AI Technologies to Optimize Health Care Processes and Improve Patient Outcomes Full Details Session Sponsored by: Petra Ritter, Germany TEF-health project – Testing and experimentation facility for health AI and robotics Petra Ritter, Germany TEF-health project – Testing and experimentation facility for health AI and robotics Caner Süsal, Turkey Data harmonization and their potential applications in organ transplantation Caner Süsal, Turkey Data harmonization and their potential applications in organ transplantation Guido Filler, Canada AI in pediatric chronic kidney disease and transplantation Guido Filler, Canada AI in pediatric chronic kidney disease and transplantation
09:30 - 10:00 \| Coffee Break
09:30-10:00	MOA 10 (Exhibit Area)	MOA 10 (Exhibit Area) 09:30 Coffee Break Sponsored by: Full Details Sponsored by:
10:00 - 11:00 \| Abstract Sessions
10:00-11:00	MOA 6	MOA 6 10:00 Mini-Oral Abstract: Specific issues in pediatric kidney transplantation Full Details Abanti Chaudhuri, United States Relationship Between AASI, Hypertension, and Left Ventricular Hypertrophy in Pediatric Kidney Transplant Patients Abanti Chaudhuri, United States Relationship Between AASI, Hypertension, and Left Ventricular Hypertrophy in Pediatric Kidney Transplant Patients Namrata G Jain, United States Impact of vesicoureteral reflux post pediatric kidney transplant: A pediatric nephrology research consortium study Namrata G Jain, United States Impact of vesicoureteral reflux post pediatric kidney transplant: A pediatric nephrology research consortium study Dorota Broniszczak-Czyszek, Poland The long-term outcome of kidney transplantation in pediatric patients with urinary tract dysfunction and a comparison of different methods of urinary outflow in children with lower urinary tract dysfunction in a single-centre experience Dorota Broniszczak-Czyszek, Poland The long-term outcome of kidney transplantation in pediatric patients with urinary tract dysfunction and a comparison of different methods of urinary outflow in children with lower urinary tract dysfunction in a single-centre experience Longshan Liu, People's Republic of China Urine-Derived Stem Cells from Kidney Transplant Recipients as a DNA Source for Genetic Testing of Suspected Inherited Kidney Diseases in Pediatric Donors Longshan Liu, People's Republic of China Urine-Derived Stem Cells from Kidney Transplant Recipients as a DNA Source for Genetic Testing of Suspected Inherited Kidney Diseases in Pediatric Donors Gema Ariceta, Spain European multi-center trial with imlifidase prior to kidney transplant in highly sensitized children Gema Ariceta, Spain European multi-center trial with imlifidase prior to kidney transplant in highly sensitized children Atessa Bahadori, Canada Kidney-alone transplantation while on siRNA therapy for Primary Hyperoxaluria type 1 Atessa Bahadori, Canada Kidney-alone transplantation while on siRNA therapy for Primary Hyperoxaluria type 1 Saruul Yu, People's Republic of China Successful early pre-emptive renal transplantation in infants with Congenital Nephrotic Syndrome of the Finnish type Saruul Yu, People's Republic of China Successful early pre-emptive renal transplantation in infants with Congenital Nephrotic Syndrome of the Finnish type Reza Saidi, United States Effects of the kidney allocation system changes in 2014, on the outcomes of kidney transplants in pediatric patients: a retrospective analysis Reza Saidi, United States Effects of the kidney allocation system changes in 2014, on the outcomes of kidney transplants in pediatric patients: a retrospective analysis
10:00-11:00	MOA 5	MOA 5 10:00 Mini-Oral Abstract: Adventures with immunosuppression Full Details Burkhard Toenshoff, Germany Unraveling interindividual differences and functional consequences of gut microbial metabolism of immunosuppressants Burkhard Toenshoff, Germany Unraveling interindividual differences and functional consequences of gut microbial metabolism of immunosuppressants Kinnari Vala, India The Induction Conundrum: To Study the Impact of Induction Immunosuppression on the Incidence of Rejections and Infections, Graft and Patient Survival in Pediatric Kidney Transplant Recipients Retrospectively Kinnari Vala, India The Induction Conundrum: To Study the Impact of Induction Immunosuppression on the Incidence of Rejections and Infections, Graft and Patient Survival in Pediatric Kidney Transplant Recipients Retrospectively Karabo Lesley K L Leotlela, South Africa Effects of calcineurin inhibitors on renal function in paediatric liver transplant recipients at a tertiary academic hospital Karabo Lesley K L Leotlela, South Africa Effects of calcineurin inhibitors on renal function in paediatric liver transplant recipients at a tertiary academic hospital Jennifer R Martin, United Kingdom A five-year retrospective review of using a steroid minimisation national protocol at a single centre: Is mycophenolate mofetil less tolerated in the younger transplant recipient? Jennifer R Martin, United Kingdom A five-year retrospective review of using a steroid minimisation national protocol at a single centre: Is mycophenolate mofetil less tolerated in the younger transplant recipient? Kinnari Vala, India Correlation between Human Leukocyte Antigen (HLA) Eplet Mismatch and Denovo Donor Specific Antibodies (dnDSA) development, in Paediatric Kidney Transplant Recipients (KTR): A Retrospective Cohort from a single Indian Centre Kinnari Vala, India Correlation between Human Leukocyte Antigen (HLA) Eplet Mismatch and Denovo Donor Specific Antibodies (dnDSA) development, in Paediatric Kidney Transplant Recipients (KTR): A Retrospective Cohort from a single Indian Centre Kai Wang, People's Republic of China Immunosuppressant withdrawal and characteristics of regulatory T cells in allograft histology among pediatric liver transplantation recipients Kai Wang, People's Republic of China Immunosuppressant withdrawal and characteristics of regulatory T cells in allograft histology among pediatric liver transplantation recipients Abanti Chaudhuri, United States Alternative, Low-Cost Monitoring of CD3 cell depletion following Anti-Thymocyte Globulin Induction in Pediatric Renal Transplant Recipients Abanti Chaudhuri, United States Alternative, Low-Cost Monitoring of CD3 cell depletion following Anti-Thymocyte Globulin Induction in Pediatric Renal Transplant Recipients Femke Vrieling-Prince, Netherlands Pubertal stage specific changes in T-cell subpopulations in healthy individuals and pediatric kidney transplant recipients Femke Vrieling-Prince, Netherlands Pubertal stage specific changes in T-cell subpopulations in healthy individuals and pediatric kidney transplant recipients
10:00-11:00	MOA 4	MOA 4 10:00 Mini-Oral Abstract: Supporting children through their transplant journey Full Details Shaan J Thomas, United States Readability of Patient and Parent Education Materials in Solid Organ Transplant Clinic - A Single Center Study Shaan J Thomas, United States Readability of Patient and Parent Education Materials in Solid Organ Transplant Clinic - A Single Center Study Astrid De Souza, Canada Virtual reality and gameplay as a model for exercise rehabilitation in pediatric solid organ transplant patients. A patient and family led initative Astrid De Souza, Canada Virtual reality and gameplay as a model for exercise rehabilitation in pediatric solid organ transplant patients. A patient and family led initative Esra Baskin, Turkey Pediatric liver and kidney transplantation: facilitating a healthy transition to adulthood and successful pregnancies Esra Baskin, Turkey Pediatric liver and kidney transplantation: facilitating a healthy transition to adulthood and successful pregnancies Tom Blydt-Hansen, Canada Social media as a tool to explore mental health in children living with a solid organ transplant and their families Tom Blydt-Hansen, Canada Social media as a tool to explore mental health in children living with a solid organ transplant and their families Mingzhu Huang, People's Republic of China Caregiver burden and discharge preparedness in pediatric liver transplantation: current status and influencing factors Mingzhu Huang, People's Republic of China Caregiver burden and discharge preparedness in pediatric liver transplantation: current status and influencing factors Lauren Scavuzzo, Canada Helping teens cope: A virtual interprofessional coronary angiogram information session Lauren Scavuzzo, Canada Helping teens cope: A virtual interprofessional coronary angiogram information session Caroline Piotrowski, Canada Young people’s perspectives of sources of support on their transplant journey Caroline Piotrowski, Canada Young people’s perspectives of sources of support on their transplant journey Yasmeen Mansoor, Canada Prevalence of household food insecurity and financial challenges amongst caregivers of paediatric chronic kidney disease, dialysis, and kidney transplant patients Yasmeen Mansoor, Canada Prevalence of household food insecurity and financial challenges amongst caregivers of paediatric chronic kidney disease, dialysis, and kidney transplant patients
10:00-11:00	MOA 3	MOA 3 10:00 Mini-Oral Abstract: Surgery - novel techniques and outcomes Full Details Davide Cussa, Italy LiverWeughtGraft-CT (LWG): an experimental model for real-time assesment of weight and volume of whole and split liver grafts for transplantation. Davide Cussa, Italy LiverWeughtGraft-CT (LWG): an experimental model for real-time assesment of weight and volume of whole and split liver grafts for transplantation. Guang-Peng Zhou, People's Republic of China First single-center experience of minimally invasive pediatric living donor liver transplantation in China Guang-Peng Zhou, People's Republic of China First single-center experience of minimally invasive pediatric living donor liver transplantation in China Adem Safak, Turkey A simple and effective approach to prevent bile leakage in biliary reconstruction: Use of a Double J catheter Adem Safak, Turkey A simple and effective approach to prevent bile leakage in biliary reconstruction: Use of a Double J catheter Isabela GG Santos, Australia Early australian experience with APOLT in children with metabolic liver disease Isabela GG Santos, Australia Early australian experience with APOLT in children with metabolic liver disease Nathália Porto Rangel Travassos, Brazil Risk factor analysis for late portal vein thrombosis in pediatric patients under 10 kilograms following living donor liver transplantation Nathália Porto Rangel Travassos, Brazil Risk factor analysis for late portal vein thrombosis in pediatric patients under 10 kilograms following living donor liver transplantation Annadiletta Donà, Italy Liver Transplantation for Pediatric Metabolic Diseases: A 15-year review of living vs deceased donor transplants at an international transplant center (2010-2025) Annadiletta Donà, Italy Liver Transplantation for Pediatric Metabolic Diseases: A 15-year review of living vs deceased donor transplants at an international transplant center (2010-2025) Isabel González-Barba Neira, Spain Monosegmental and hyperreduced split grafts to overcome large-for-size scenarios in pediatric liver transplants Isabel González-Barba Neira, Spain Monosegmental and hyperreduced split grafts to overcome large-for-size scenarios in pediatric liver transplants Alessandra Rancan, France Surgical outcomes of liver transplantation in pediatric organic acidemias Alessandra Rancan, France Surgical outcomes of liver transplantation in pediatric organic acidemias
11:05 - 12:05 \| Concurrent Workshop Sessions
11:05-12:05	MOA 6	MOA 6 11:05 Workshop: Histocompatibility Full Details Lecture Sponsored by: Anat R Tambur, United States New Insights into HLA-DQ immunogenicity Anat R Tambur, United States New Insights into HLA-DQ immunogenicity Nils Lachmann, Germany How to use virtual crossmatching Nils Lachmann, Germany How to use virtual crossmatching Burkhard Toenshoff, Germany Tailoring HLA antibody monitoring post transplantation Burkhard Toenshoff, Germany Tailoring HLA antibody monitoring post transplantation
11:05-12:05	MOA 5	MOA 5 11:05 Workshop: IPTA-SPLIT: Cardiac liver disease Full Details Session Sponsored by: Chaowapong Jarasvaraparn, United States Congestive hepatopathy: Risks, surveillance and management Chaowapong Jarasvaraparn, United States Congestive hepatopathy: Risks, surveillance and management Alyssa Kriegermeier, United States Liver biopsy is key: The importance of a liver biopsy for disease management and long-term predictions Alyssa Kriegermeier, United States Liver biopsy is key: The importance of a liver biopsy for disease management and long-term predictions Elizabeth Rand, United States Liver biopsy is too risky without reward: Alternative ways to monitor congestive hepatopathy and why liver biopsy is not needed Elizabeth Rand, United States Liver biopsy is too risky without reward: Alternative ways to monitor congestive hepatopathy and why liver biopsy is not needed Alyssa Kriegermeier, United States Pro liver biopsy response Alyssa Kriegermeier, United States Pro liver biopsy response Elizabeth Rand, United States Con liver biopsy response Elizabeth Rand, United States Con liver biopsy response Discussion Period, Germany Questions from Audience Discussion Period, Germany Questions from Audience
11:05-12:05	MOA 4	MOA 4 11:05 Workshop: Trauma informed care in pediatric solid organ transplant: Learning and growing Full Details Louise Clegg, United Kingdom Creating Trauma Informed Pathways Louise Clegg, United Kingdom Creating Trauma Informed Pathways Louise Clegg, United Kingdom Patient Perspective (pre-recorded presentation) Louise Clegg, United Kingdom Patient Perspective (pre-recorded presentation) Gillian S Mayersohn, United States Post traumatic growth Gillian S Mayersohn, United States Post traumatic growth Discussion Period, Germany Panel Discussion Discussion Period, Germany Panel Discussion
11:05-12:05	MOA 3	MOA 3 11:05 Workshop: Breaking down barriers to transplant in low resource settings Full Details Hanh D Vo, United States Transplant without borders: IPTA guidance on developing pediatric SOT programs in low and middle income countries Hanh D Vo, United States Transplant without borders: IPTA guidance on developing pediatric SOT programs in low and middle income countries Priya Walabh, South Africa Tale of 2 cities: Public-private disparity in transplant access Priya Walabh, South Africa Tale of 2 cities: Public-private disparity in transplant access Olivia Boyer, France Ties that bind: IPTA Outreach partnerships (co-presenting) Olivia Boyer, France Ties that bind: IPTA Outreach partnerships (co-presenting) Mignon McCulloch, South Africa Panel discussion on the challenges of access to transplant and innovative solutions: Africa perspective Mignon McCulloch, South Africa Panel discussion on the challenges of access to transplant and innovative solutions: Africa perspective Katherine E. Twombley, United States Panel discussion on the challenges of access to transplant and innovative solutions: IPTA perspective Katherine E. Twombley, United States Panel discussion on the challenges of access to transplant and innovative solutions: IPTA perspective Vindya N Gunasekara Sr., Sri Lanka Panel discussion on the challenges of access to transplant and innovative solutions: South Asian perspective Vindya N Gunasekara Sr., Sri Lanka Panel discussion on the challenges of access to transplant and innovative solutions: South Asian perspective Benas Prusinskas, Lithuania Panel discussion on the challenges of access to transplant and innovative solutions: Baltic perspective Benas Prusinskas, Lithuania Panel discussion on the challenges of access to transplant and innovative solutions: Baltic perspective Dominique M. Jan, United States Panel discussion on the challenges of access to transplant and innovative solutions: Surgeon perspective Dominique M. Jan, United States Panel discussion on the challenges of access to transplant and innovative solutions: Surgeon perspective
12:05 - 13:30 \| Lunch Break & Industry Symposium
12:05-13:35	MOA 10 (Exhibit Area)	MOA 10 (Exhibit Area) 12:05 Lunch Break Full Details
12:20-13:20	MOA 9 (Plenary Room)	MOA 9 (Plenary Room) 12:20 Industry Symposium: Kidney injury perspectives for heart, kidney and liver transplant: Cases using NGAL Full Details Session Sponsored by: Jun Oh, Germany Jun Oh, Germany Kyle A Merrill, United States Kyle A Merrill, United States Discussion Period, Germany Q&A with the audience Discussion Period, Germany Q&A with the audience
13:35 - 15:05 \| Abstract Sessions
13:35-15:05	MOA 6	MOA 6 13:35 Oral Abstract: Improving survival following pediatric kidney transplant Full Details Dechu Puliyanda, United States Successful use of daratumumab (Anti-CD38) for the treatment of pediatric post-transplant proteinuric diseases: A case series Dechu Puliyanda, United States Successful use of daratumumab (Anti-CD38) for the treatment of pediatric post-transplant proteinuric diseases: A case series Zachary Oatley, United States Tolerating Unfavorable Donor Criteria in Pediatric Kidney Transplantation: A Retrospective UNOS Analysis Zachary Oatley, United States Tolerating Unfavorable Donor Criteria in Pediatric Kidney Transplantation: A Retrospective UNOS Analysis Priya Verghese, United States Low-Density Lipoprotein Apheresis for Recurrent Nephrotic Syndrome in Pediatric Kidney Recipients: A Systematic Review and Meta-Analysis Priya Verghese, United States Low-Density Lipoprotein Apheresis for Recurrent Nephrotic Syndrome in Pediatric Kidney Recipients: A Systematic Review and Meta-Analysis Binnaz Handan Ozdemir, Turkey Age-dependent differences in pediatric versus adult kidney transplantation: ımpaired VEGF and NO signaling weaken microvascular ıntegrity and threaten renal graft survival Binnaz Handan Ozdemir, Turkey Age-dependent differences in pediatric versus adult kidney transplantation: ımpaired VEGF and NO signaling weaken microvascular ıntegrity and threaten renal graft survival Agnieszka Swiatecka-Urban, United States Risk stratification of chronic kidney allograft failure in donor-recipient (D-R) pairs Agnieszka Swiatecka-Urban, United States Risk stratification of chronic kidney allograft failure in donor-recipient (D-R) pairs Nicos Kessaris, United Kingdom Long-term Outcomes of Paediatric Kidney Transplants from DCD donors are comparable to those from DBD donors: a 33-year Comparative OPTN study Nicos Kessaris, United Kingdom Long-term Outcomes of Paediatric Kidney Transplants from DCD donors are comparable to those from DBD donors: a 33-year Comparative OPTN study Nicos Kessaris, United Kingdom Long-term outcomes of right versus left kidney transplants over a 33-year period in the USA – a comparative study Nicos Kessaris, United Kingdom Long-term outcomes of right versus left kidney transplants over a 33-year period in the USA – a comparative study Longshan Liu, People's Republic of China Impaired renal function at 1-year after for-cause biopsy affected long-term graft survival in pediatric kidney transplant recipients Longshan Liu, People's Republic of China Impaired renal function at 1-year after for-cause biopsy affected long-term graft survival in pediatric kidney transplant recipients
13:35-15:05	MOA 5	MOA 5 13:35 Oral Abstract: Indications for pediatric liver transplantation Full Details Marshall W Wallace, United States Proactive living donor liver transplant is associated with improved graft- and patient-survival outcomes in children with Biliary Atresia Marshall W Wallace, United States Proactive living donor liver transplant is associated with improved graft- and patient-survival outcomes in children with Biliary Atresia Maria Julia Minetto, Argentina Facing the issue of acute-on-chronic liver failure in pediatric biliary atresia: a prognostic and therapeutic challenge Maria Julia Minetto, Argentina Facing the issue of acute-on-chronic liver failure in pediatric biliary atresia: a prognostic and therapeutic challenge Joao Seda Neto, Brazil Living donor plus domino liver transplantation for MSUD: expanding donor pool safely Joao Seda Neto, Brazil Living donor plus domino liver transplantation for MSUD: expanding donor pool safely Alberto M Fratti, Italy Liver transplant for the treatment of hepatocellular carcinoma in children exceeding milan criteria Alberto M Fratti, Italy Liver transplant for the treatment of hepatocellular carcinoma in children exceeding milan criteria Douglas G. Farmer, United States Excellent outcomes with high-risk pediatric hepatoblastoma: a detailed analysis of a large, single center experience Douglas G. Farmer, United States Excellent outcomes with high-risk pediatric hepatoblastoma: a detailed analysis of a large, single center experience Fady M Kaldas, United States Pediatric liver re-transplantation over 40 years: the largest comprehensive single-center experience Fady M Kaldas, United States Pediatric liver re-transplantation over 40 years: the largest comprehensive single-center experience Samira Sissaoui, France Mid- and long-term evolution after liver +/- kidney transplantation for methylmalonic acidemia Samira Sissaoui, France Mid- and long-term evolution after liver +/- kidney transplantation for methylmalonic acidemia
13:35-15:05	MOA 4	MOA 4 13:35 Oral Abstract: Everyday challenges in psychosocial assessment and care Full Details Debra Lefkowitz, United States Thriving through adversity: Post-traumatic growth among caregivers one month after solid organ transplant Debra Lefkowitz, United States Thriving through adversity: Post-traumatic growth among caregivers one month after solid organ transplant Michael JG Somers, United States Sun safety knowledge and practice after pediatric solid organ transplantation: an Interdisciplinary approach Michael JG Somers, United States Sun safety knowledge and practice after pediatric solid organ transplantation: an Interdisciplinary approach Annette Nasr, United States “Behind every scar there is an untold story of survival” giving voice to untold stories from parental live liver donors and adolescent recipients Annette Nasr, United States “Behind every scar there is an untold story of survival” giving voice to untold stories from parental live liver donors and adolescent recipients Shi Tang, People's Republic of China Factors influencing immunosuppressive medication adherence in adolescents after liver transplantation: A parallel mediation analysis based on the Health Belief Model and Social Cognitive Theory Shi Tang, People's Republic of China Factors influencing immunosuppressive medication adherence in adolescents after liver transplantation: A parallel mediation analysis based on the Health Belief Model and Social Cognitive Theory Kate Rokoss, Canada Effectively engaging high school students about organ donation and transplantation: An update on the high school outreach initiative experience Kate Rokoss, Canada Effectively engaging high school students about organ donation and transplantation: An update on the high school outreach initiative experience Daniel S Thomson, United States Substance use patterns in pediatric solid organ transplant candidates: impact after transplant Daniel S Thomson, United States Substance use patterns in pediatric solid organ transplant candidates: impact after transplant Kaushalendra Amatya, United States Sexual and reproductive health knowledge in post-transplant adolescents and young adults Kaushalendra Amatya, United States Sexual and reproductive health knowledge in post-transplant adolescents and young adults Tom Blydt-Hansen, Canada Evaluating patterns of social media use in children living with a solid organ transplant and their families Tom Blydt-Hansen, Canada Evaluating patterns of social media use in children living with a solid organ transplant and their families Chase Samsel, United States Delirium risk screening, occurrence, and associated psychosocial and psychiatric risk factors in a large cardiopulmonary pre-transplant population Chase Samsel, United States Delirium risk screening, occurrence, and associated psychosocial and psychiatric risk factors in a large cardiopulmonary pre-transplant population
13:35-15:05	MOA 3	MOA 3 13:35 Oral Abstract: Breakthroughs not outbreaks - ID and PTLD Full Details Alexander Fichtner, Germany Prevention of human papillomavirus (HPV) infection in pediatric kidney (KTx) and liver transplant recipients (LTx) and in pediatric patients with advanced chronic kidney disease (CKD): a prospective, multicenter vaccine surveillance trial (HPVaxResponse study) Alexander Fichtner, Germany Prevention of human papillomavirus (HPV) infection in pediatric kidney (KTx) and liver transplant recipients (LTx) and in pediatric patients with advanced chronic kidney disease (CKD): a prospective, multicenter vaccine surveillance trial (HPVaxResponse study) Daniel Dulek, United States Multicenter Prospective Cohort Study of CMV T cell Immunity and First post-transplant CMV DNAemia in Pediatric Solid Organ Transplant Recipients Daniel Dulek, United States Multicenter Prospective Cohort Study of CMV T cell Immunity and First post-transplant CMV DNAemia in Pediatric Solid Organ Transplant Recipients Dorota Broniszczak-Czyszek, Poland Complete withdrawal of immunosuppression and long-term graft function in pediatric liver recipients who developed PTLD or EBV infection Dorota Broniszczak-Czyszek, Poland Complete withdrawal of immunosuppression and long-term graft function in pediatric liver recipients who developed PTLD or EBV infection Michael Green, United States Impact of Epstein Barr Virus (EBV) status of lesions, 2016 WHO histologic grade and time of onset on outcome of Post-Transplant Lymphoproliferative Disorder (PTLD) in pediatric solid organ transplant (SOT) and hematopoietic stem cell transplant (HCT) recipients: Results of a prospective/retrospective multicenter study Michael Green, United States Impact of Epstein Barr Virus (EBV) status of lesions, 2016 WHO histologic grade and time of onset on outcome of Post-Transplant Lymphoproliferative Disorder (PTLD) in pediatric solid organ transplant (SOT) and hematopoietic stem cell transplant (HCT) recipients: Results of a prospective/retrospective multicenter study Charlotte Duneton, France Pretransplant BK Virus Immunity in Pediatric Kidney Transplantation: Predictive Markers and Role of IVIg Prophylaxis Charlotte Duneton, France Pretransplant BK Virus Immunity in Pediatric Kidney Transplantation: Predictive Markers and Role of IVIg Prophylaxis Sonya R Kowalczyk, United States Surveillance of Post-Transplant Lymphoproliferative Disorder in Pediatric Solid Organ Transplant Recipients Sonya R Kowalczyk, United States Surveillance of Post-Transplant Lymphoproliferative Disorder in Pediatric Solid Organ Transplant Recipients Alejandro Zarauza Santoveña, Spain Adoptive cell therapy based on CD45RO+/RA- memory lymphocites infusions to treat BK virus-associated nefropathy in kidney transplant patients. Alejandro Zarauza Santoveña, Spain Adoptive cell therapy based on CD45RO+/RA- memory lymphocites infusions to treat BK virus-associated nefropathy in kidney transplant patients. Sharath M Manya, United Kingdom Neonatal acute liver failure secondary to enteroviruses: Outcome with or without liver transplantation Sharath M Manya, United Kingdom Neonatal acute liver failure secondary to enteroviruses: Outcome with or without liver transplantation Sharath M Manya, United Kingdom The role of the fungal biomarker Beta-D-Glucan (BDG) in diagnosing and guiding antifungal prescribing for fungal infections in paediatric liver and multivisceral transplant recipients Sharath M Manya, United Kingdom The role of the fungal biomarker Beta-D-Glucan (BDG) in diagnosing and guiding antifungal prescribing for fungal infections in paediatric liver and multivisceral transplant recipients
15:10 - 16:10 \| Concurrent Workshop Sessions
15:10-16:10	MOA 6	MOA 6 15:10 Workshop: Primary hyperoxaluria: Therapeutic options to surpass inequities in access Full Details Session Sponsored by: Bernd Hoppe, Germany Treatment of choice – siRNAs, The Cure? Bernd Hoppe, Germany Treatment of choice – siRNAs, The Cure? Mignon McCulloch, South Africa Management options in LMICs Mignon McCulloch, South Africa Management options in LMICs Anne-Laure Sellier-Leclerc, France Medical management post-KTx in patients with PH1 Anne-Laure Sellier-Leclerc, France Medical management post-KTx in patients with PH1 Discussion Period, Germany Panel Discussion Discussion Period, Germany Panel Discussion
15:10-16:10	MOA 5	MOA 5 15:10 Workshop: Hot topics in pediatric liver transplantation Full Details Yaron Avitzur, Canada Atopy and allergy after paediatric liver transplant Yaron Avitzur, Canada Atopy and allergy after paediatric liver transplant Jun Oh, Germany Where are we at with gene therapy for inherited metabolic diseases? Jun Oh, Germany Where are we at with gene therapy for inherited metabolic diseases? Diana Mager, Canada Stollery children’s-fatigue and sarcopenia interventions in pediatric liver transplants (pre-recorded presentation) Diana Mager, Canada Stollery children’s-fatigue and sarcopenia interventions in pediatric liver transplants (pre-recorded presentation)
15:10-16:10	MOA 4	MOA 4 15:10 Workshop: New horizons in theranostics for pediatric solid organ transplant Full Details Satish N. Nadig, United States Targeted nanotherapeutics in pediatric transplantation Satish N. Nadig, United States Targeted nanotherapeutics in pediatric transplantation Paulo Martins, United States Novel insights and therapeutic applications of normothermic perfusion in pediatric transplant Paulo Martins, United States Novel insights and therapeutic applications of normothermic perfusion in pediatric transplant Stephen Alexander, Australia Organ transplant tolerance in children Stephen Alexander, Australia Organ transplant tolerance in children
15:10-16:10	MOA 3	MOA 3 15:10 Workshop: IPTA-AST: Dealing with Dilemmas: Challenging Cases in Pediatric Transplantation Full Details Session Sponsored by: Katherine E. Twombley, United States Challenging dermatologic cases Katherine E. Twombley, United States Challenging dermatologic cases Roshan George, United States Challenges HLA cases Roshan George, United States Challenges HLA cases Juan Carlos Caicedo-Ramirez, United States Challenging abdominal surgical cases Juan Carlos Caicedo-Ramirez, United States Challenging abdominal surgical cases
16:10 - 16:40 \| Coffee Break
16:10-16:40	MOA 10 (Exhibit Area)	MOA 10 (Exhibit Area) 16:10 Coffee Break Sponsored by: Full Details Sponsored by:
16:40 - 05:45 \| State-of-the-Art Sessions
16:40-17:10	MOA 9 (Plenary Room)	MOA 9 (Plenary Room) 16:40 SOTA: Immunomonitoring to predicting infections in solid organ transplant recipients Full Details Session Sponsored by: Martina Sester, Germany Immunomonitoring to predict infection in SOT recipients Martina Sester, Germany Immunomonitoring to predict infection in SOT recipients
17:15-17:45	MOA 9 (Plenary Room)	MOA 9 (Plenary Room) 17:15 SOTA: Immunometabolism and how an allograft's energy signatures affect cellular immunity Full Details Stefan G. Tullius, United States Immunometabolism and how an allograft's energy signatures affect cellular immunity Stefan G. Tullius, United States Immunometabolism and how an allograft's energy signatures affect cellular immunity
19:00 - 22:00 \| Congress Networking Event
19:00-22:00	Das Lemke Brewery	Das Lemke Brewery 19:00 Networking Event: Congress Dinner Full Details

07:00-08:00

MOA 6

07:00

Morning Session: SickKids: Empowering adolescents: Team-based multidisciplinary care

Full Details

A light breakfast will be served

Session Sponsored by:

Amelia Marrato, Canada
Panelist: Nurse practitioner perspective

Louise Bannister, Canada
Panelist: Dietitian perspective

Anna Gold, Canada
Panelist: Psychologist perspective

Akila Dada, Canada
Panelist: Child life specialist perspective

Alison Schwartz, Canada
Panelist: Occupational therapist perspective

Robin Deliva, Canada
Panelist: Physical therapist perspective

07:00-07:50

MOA 5

07:00

Oral Abstract: Understanding rejection in pediatric kidney transplant

Full Details

Alanoud Alshami, Saudi Arabia
Utility of De Novo Donor-Specific Antibody-Driven Protocol Kidney Biopsy in Pediatric Kidney Transplantaion

Jessica Schmitz, Germany
Immunohistochemical and molecular characterization of immune cells in pediatric renal allografts: mononuclear phagocytes correlate with rejection, retransplantation, graft function and fibrosis

Evgenia Preka, France
Urinary and blood mRNA biomarkers for detecting kidney allograft rejection in adults (The KTD-Innov study: NCT03582436)

Anika Shah, United States
Impact of Specific HLA-DR Mismatches on De Novo Donor-Specific Antibody Formation in Pediatric Kidney Transplantation

Clarkson Crane, United States
Use of tissue-based gene expression alongside histology improves clinical decision-making in pediatric kidney transplant recipients

07:00-07:50

MOA 3

07:00

Oral Abstract: Advances in transplant surgery

Full Details

Joao Seda Neto, Brazil
Anterior hepatic resection for infant LDLT: Medium-term outcomes

Amanda R Jensen, United States
Split liver transplantation using machine perfusion in pediatric recipients

Renana Yemini, United States
Intra-operative flow rates in technical variant pediatric liver transplantation: Measurement distribution and a potential predictor of post-operative vascular complications – A Starzl Network Initiative

Isabela GG Santos, Australia
Australian experience with APOLT in children with FLF

Reza Saidi, United States
Single vs. en bloc kidney transplantation from donors ≤5 years of age in the United States: An analysis of the scientific registry of transplant recipients (SRTR) from 1987 to 2023

08:00-09:30

MOA 9 (Plenary Room)

08:00

Plenary Session: Artificial Intelligence (AI) in Health Care: Integration of AI Technologies to Optimize Health Care Processes and Improve Patient Outcomes

Full Details

Session Sponsored by:

Petra Ritter, Germany
TEF-health project – Testing and experimentation facility for health AI and robotics

Caner Süsal, Turkey
Data harmonization and their potential applications in organ transplantation

Guido Filler, Canada
AI in pediatric chronic kidney disease and transplantation

09:30-10:00

MOA 10 (Exhibit Area)

09:30

Coffee Break
Sponsored by:

Full Details

Sponsored by:

10:00-11:00

MOA 6

10:00

Mini-Oral Abstract: Specific issues in pediatric kidney transplantation

Full Details

Abanti Chaudhuri, United States
Relationship Between AASI, Hypertension, and Left Ventricular Hypertrophy in Pediatric Kidney Transplant Patients

Namrata G Jain, United States
Impact of vesicoureteral reflux post pediatric kidney transplant: A pediatric nephrology research consortium study

Dorota Broniszczak-Czyszek, Poland
The long-term outcome of kidney transplantation in pediatric patients with urinary tract dysfunction and a comparison of different methods of urinary outflow in children with lower urinary tract dysfunction in a single-centre experience

Longshan Liu, People's Republic of China
Urine-Derived Stem Cells from Kidney Transplant Recipients as a DNA Source for Genetic Testing of Suspected Inherited Kidney Diseases in Pediatric Donors

Gema Ariceta, Spain
European multi-center trial with imlifidase prior to kidney transplant in highly sensitized children

Atessa Bahadori, Canada
Kidney-alone transplantation while on siRNA therapy for Primary Hyperoxaluria type 1

Saruul Yu, People's Republic of China
Successful early pre-emptive renal transplantation in infants with Congenital Nephrotic Syndrome of the Finnish type

Reza Saidi, United States
Effects of the kidney allocation system changes in 2014, on the outcomes of kidney transplants in pediatric patients: a retrospective analysis

10:00-11:00

MOA 5

10:00

Mini-Oral Abstract: Adventures with immunosuppression

Full Details

Burkhard Toenshoff, Germany
Unraveling interindividual differences and functional consequences of gut microbial metabolism of immunosuppressants

Kinnari Vala, India
The Induction Conundrum: To Study the Impact of Induction Immunosuppression on the Incidence of Rejections and Infections, Graft and Patient Survival in Pediatric Kidney Transplant Recipients Retrospectively

Karabo Lesley K L Leotlela, South Africa
Effects of calcineurin inhibitors on renal function in paediatric liver transplant recipients at a tertiary academic hospital

Jennifer R Martin, United Kingdom
A five-year retrospective review of using a steroid minimisation national protocol at a single centre: Is mycophenolate mofetil less tolerated in the younger transplant recipient?

Kinnari Vala, India
Correlation between Human Leukocyte Antigen (HLA) Eplet Mismatch and Denovo Donor Specific Antibodies (dnDSA) development, in Paediatric Kidney Transplant Recipients (KTR): A Retrospective Cohort from a single Indian Centre

Kai Wang, People's Republic of China
Immunosuppressant withdrawal and characteristics of regulatory T cells in allograft histology among pediatric liver transplantation recipients

Abanti Chaudhuri, United States
Alternative, Low-Cost Monitoring of CD3 cell depletion following Anti-Thymocyte Globulin Induction in Pediatric Renal Transplant Recipients

Femke Vrieling-Prince, Netherlands
Pubertal stage specific changes in T-cell subpopulations in healthy individuals and pediatric kidney transplant recipients

10:00-11:00

MOA 4

10:00

Mini-Oral Abstract: Supporting children through their transplant journey

Full Details

Shaan J Thomas, United States
Readability of Patient and Parent Education Materials in Solid Organ Transplant Clinic - A Single Center Study

Astrid De Souza, Canada
Virtual reality and gameplay as a model for exercise rehabilitation in pediatric solid organ transplant patients. A patient and family led initative

Esra Baskin, Turkey
Pediatric liver and kidney transplantation: facilitating a healthy transition to adulthood and successful pregnancies

Tom Blydt-Hansen, Canada
Social media as a tool to explore mental health in children living with a solid organ transplant and their families

Mingzhu Huang, People's Republic of China
Caregiver burden and discharge preparedness in pediatric liver transplantation: current status and influencing factors

Lauren Scavuzzo, Canada
Helping teens cope: A virtual interprofessional coronary angiogram information session

Caroline Piotrowski, Canada
Young people’s perspectives of sources of support on their transplant journey

Yasmeen Mansoor, Canada
Prevalence of household food insecurity and financial challenges amongst caregivers of paediatric chronic kidney disease, dialysis, and kidney transplant patients

10:00-11:00

MOA 3

10:00

Mini-Oral Abstract: Surgery - novel techniques and outcomes

Full Details

Davide Cussa, Italy
LiverWeughtGraft-CT (LWG): an experimental model for real-time assesment of weight and volume of whole and split liver grafts for transplantation.

Guang-Peng Zhou, People's Republic of China
First single-center experience of minimally invasive pediatric living donor liver transplantation in China

Adem Safak, Turkey
A simple and effective approach to prevent bile leakage in biliary reconstruction: Use of a Double J catheter

Isabela GG Santos, Australia
Early australian experience with APOLT in children with metabolic liver disease

Nathália Porto Rangel Travassos, Brazil
Risk factor analysis for late portal vein thrombosis in pediatric patients under 10 kilograms following living donor liver transplantation

Annadiletta Donà, Italy
Liver Transplantation for Pediatric Metabolic Diseases: A 15-year review of living vs deceased donor transplants at an international transplant center (2010-2025)

Isabel González-Barba Neira, Spain
Monosegmental and hyperreduced split grafts to overcome large-for-size scenarios in pediatric liver transplants

Alessandra Rancan, France
Surgical outcomes of liver transplantation in pediatric organic acidemias

11:05-12:05

MOA 6

11:05

Workshop: Histocompatibility

Full Details

Lecture Sponsored by:

Anat R Tambur, United States
New Insights into HLA-DQ immunogenicity

Nils Lachmann, Germany
How to use virtual crossmatching

Burkhard Toenshoff, Germany
Tailoring HLA antibody monitoring post transplantation

11:05-12:05

MOA 5

11:05

Workshop: IPTA-SPLIT: Cardiac liver disease

Full Details

Session Sponsored by:

Chaowapong Jarasvaraparn, United States
Congestive hepatopathy: Risks, surveillance and management

Alyssa Kriegermeier, United States
Liver biopsy is key: The importance of a liver biopsy for disease management and long-term predictions

Elizabeth Rand, United States
Liver biopsy is too risky without reward: Alternative ways to monitor congestive hepatopathy and why liver biopsy is not needed

Alyssa Kriegermeier, United States
Pro liver biopsy response

Elizabeth Rand, United States
Con liver biopsy response

Discussion Period, Germany
Questions from Audience

11:05-12:05

MOA 4

11:05

Workshop: Trauma informed care in pediatric solid organ transplant: Learning and growing

Full Details

Louise Clegg, United Kingdom
Creating Trauma Informed Pathways

Louise Clegg, United Kingdom
Patient Perspective (pre-recorded presentation)

Gillian S Mayersohn, United States
Post traumatic growth

Discussion Period, Germany
Panel Discussion

11:05-12:05

MOA 3

11:05

Workshop: Breaking down barriers to transplant in low resource settings

Full Details

Hanh D Vo, United States
Transplant without borders: IPTA guidance on developing pediatric SOT programs in low and middle income countries

Priya Walabh, South Africa
Tale of 2 cities: Public-private disparity in transplant access

Olivia Boyer, France
Ties that bind: IPTA Outreach partnerships (co-presenting)

Mignon McCulloch, South Africa
Panel discussion on the challenges of access to transplant and innovative solutions: Africa perspective

Katherine E. Twombley, United States
Panel discussion on the challenges of access to transplant and innovative solutions: IPTA perspective

Vindya N Gunasekara Sr., Sri Lanka
Panel discussion on the challenges of access to transplant and innovative solutions: South Asian perspective

Benas Prusinskas, Lithuania
Panel discussion on the challenges of access to transplant and innovative solutions: Baltic perspective

Dominique M. Jan, United States
Panel discussion on the challenges of access to transplant and innovative solutions: Surgeon perspective

12:05-13:35

MOA 10 (Exhibit Area)

12:05

Lunch Break

Full Details

12:20-13:20

MOA 9 (Plenary Room)

12:20

Industry Symposium: Kidney injury perspectives for heart, kidney and liver transplant: Cases using NGAL

Full Details

Session Sponsored by:

Jun Oh, Germany

Kyle A Merrill, United States

Discussion Period, Germany
Q&A with the audience

13:35-15:05

MOA 6

13:35

Oral Abstract: Improving survival following pediatric kidney transplant

Full Details

Dechu Puliyanda, United States
Successful use of daratumumab (Anti-CD38) for the treatment of pediatric post-transplant proteinuric diseases: A case series

Zachary Oatley, United States
Tolerating Unfavorable Donor Criteria in Pediatric Kidney Transplantation: A Retrospective UNOS Analysis

Priya Verghese, United States
Low-Density Lipoprotein Apheresis for Recurrent Nephrotic Syndrome in Pediatric Kidney Recipients: A Systematic Review and Meta-Analysis

Binnaz Handan Ozdemir, Turkey
Age-dependent differences in pediatric versus adult kidney transplantation: ımpaired VEGF and NO signaling weaken microvascular ıntegrity and threaten renal graft survival

Agnieszka Swiatecka-Urban, United States
Risk stratification of chronic kidney allograft failure in donor-recipient (D-R) pairs

Nicos Kessaris, United Kingdom
Long-term Outcomes of Paediatric Kidney Transplants from DCD donors are comparable to those from DBD donors: a 33-year Comparative OPTN study

Nicos Kessaris, United Kingdom
Long-term outcomes of right versus left kidney transplants over a 33-year period in the USA – a comparative study

Longshan Liu, People's Republic of China
Impaired renal function at 1-year after for-cause biopsy affected long-term graft survival in pediatric kidney transplant recipients

13:35-15:05

MOA 5

13:35

Oral Abstract: Indications for pediatric liver transplantation

Full Details

Marshall W Wallace, United States
Proactive living donor liver transplant is associated with improved graft- and patient-survival outcomes in children with Biliary Atresia

Maria Julia Minetto, Argentina
Facing the issue of acute-on-chronic liver failure in pediatric biliary atresia: a prognostic and therapeutic challenge

Joao Seda Neto, Brazil
Living donor plus domino liver transplantation for MSUD: expanding donor pool safely

Alberto M Fratti, Italy
Liver transplant for the treatment of hepatocellular carcinoma in children exceeding milan criteria

Douglas G. Farmer, United States
Excellent outcomes with high-risk pediatric hepatoblastoma: a detailed analysis of a large, single center experience

Fady M Kaldas, United States
Pediatric liver re-transplantation over 40 years: the largest comprehensive single-center experience

Samira Sissaoui, France
Mid- and long-term evolution after liver +/- kidney transplantation for methylmalonic acidemia

13:35-15:05

MOA 4

13:35

Oral Abstract: Everyday challenges in psychosocial assessment and care

Full Details

Debra Lefkowitz, United States
Thriving through adversity: Post-traumatic growth among caregivers one month after solid organ transplant

Michael JG Somers, United States
Sun safety knowledge and practice after pediatric solid organ transplantation: an Interdisciplinary approach

Annette Nasr, United States
“Behind every scar there is an untold story of survival” giving voice to untold stories from parental live liver donors and adolescent recipients

Shi Tang, People's Republic of China
Factors influencing immunosuppressive medication adherence in adolescents after liver transplantation: A parallel mediation analysis based on the Health Belief Model and Social Cognitive Theory

Kate Rokoss, Canada
Effectively engaging high school students about organ donation and transplantation: An update on the high school outreach initiative experience

Daniel S Thomson, United States
Substance use patterns in pediatric solid organ transplant candidates: impact after transplant

Kaushalendra Amatya, United States
Sexual and reproductive health knowledge in post-transplant adolescents and young adults

Tom Blydt-Hansen, Canada
Evaluating patterns of social media use in children living with a solid organ transplant and their families

Chase Samsel, United States
Delirium risk screening, occurrence, and associated psychosocial and psychiatric risk factors in a large cardiopulmonary pre-transplant population

13:35-15:05

MOA 3

13:35

Oral Abstract: Breakthroughs not outbreaks - ID and PTLD

Full Details

Alexander Fichtner, Germany
Prevention of human papillomavirus (HPV) infection in pediatric kidney (KTx) and liver transplant recipients (LTx) and in pediatric patients with advanced chronic kidney disease (CKD): a prospective, multicenter vaccine surveillance trial (HPVaxResponse study)

Daniel Dulek, United States
Multicenter Prospective Cohort Study of CMV T cell Immunity and First post-transplant CMV DNAemia in Pediatric Solid Organ Transplant Recipients

Dorota Broniszczak-Czyszek, Poland
Complete withdrawal of immunosuppression and long-term graft function in pediatric liver recipients who developed PTLD or EBV infection

Michael Green, United States
Impact of Epstein Barr Virus (EBV) status of lesions, 2016 WHO histologic grade and time of onset on outcome of Post-Transplant Lymphoproliferative Disorder (PTLD) in pediatric solid organ transplant (SOT) and hematopoietic stem cell transplant (HCT) recipients: Results of a prospective/retrospective multicenter study

Charlotte Duneton, France
Pretransplant BK Virus Immunity in Pediatric Kidney Transplantation: Predictive Markers and Role of IVIg Prophylaxis

Sonya R Kowalczyk, United States
Surveillance of Post-Transplant Lymphoproliferative Disorder in Pediatric Solid Organ Transplant Recipients

Alejandro Zarauza Santoveña, Spain
Adoptive cell therapy based on CD45RO+/RA- memory lymphocites infusions to treat BK virus-associated nefropathy in kidney transplant patients.

Sharath M Manya, United Kingdom
Neonatal acute liver failure secondary to enteroviruses: Outcome with or without liver transplantation

Sharath M Manya, United Kingdom
The role of the fungal biomarker Beta-D-Glucan (BDG) in diagnosing and guiding antifungal prescribing for fungal infections in paediatric liver and multivisceral transplant recipients